Successful Portfolio Restructuring
Hillenbrand announced the sale of 51% of its Milacron injection molding and extrusion business to Bain Capital for $287 million. This move is part of a strategic shift towards a higher margin, higher growth portfolio.
Strong Performance in Food, Health, and Nutrition (FHN)
Record orders in FHN end markets, with increased demand across baked goods, pet foods, snacks, cereals, and pharmaceuticals, particularly in North America.
Aftermarket Orders Reach New Record
Aftermarket orders in the APS segment reached a new record level, driven by modernization projects and proactive aftermarket strategies.
Improved Working Capital Efficiency
Cash flow from operations improved by $13 million compared to the prior year due to better working capital efficiency.